Norbert Bischofberger

Norbert Bischofberger (born 10 January 1954 in Mellau ) is an Austrian biochemist and developer of the influenza therapeutic Tamiflu and other drugs for other infectious diseases, such as HIV therapeutic Viread.

Life

Norbert Bischofberger grew up in Mellau in the Bregenz Forest ( Vorarlberg), where his parents owned an inn on. He is the second youngest of six children. His interest in science was sparked in childhood according to own data.

After primary school in Mellau Bischofberger visited the Cistercian school Mehrerau in Bregenz, where he graduated with the Matura. After studying chemistry at the University of Innsbruck. Then he took a doctorate at the ETH Zurich.

Despite various offers presented by European chemicals groups migrates Norbert Bischofberger, 1981 in the U.S. and graduated from Harvard University in Cambridge, Massachusetts, his postgraduate studies. After that, he remained in the U.S. and works since 1990 for Gilead Sciences, the Vice President, he is since 2000.

Inspired by the preparations " amantadine " and " rimantadine ", each of which could only fight a flu types and also showed strong side effects, Bischofberger and his team developed in 1994 the drug " Tamiflu " and subsequently seven more, highly effective agent against viral diseases.

2006 bought Bischofberger, Hotel Sonne is at the center of Mellau, which formerly belonged to his family. From March to December 2008, he was general renovate its headquarters and expand the hotel complex to the 4- star superior hotel. The hotel was re-opened on 12 December 2008. In the spring of 2009, the Sun Lifestyle Resort was awarded the Vorarlberg Holzbaupreis.